Latest News about IMPL
Recent news which mentions IMPL
From Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
From Benzinga
Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target
May 13, 2022
From Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
From Benzinga
From Benzinga
From Benzinga
Impel Neuro's Trudhesa Nasal Spray Migraine Treatment Performed Better Than Expected In Q4
January 18, 2022
Tickers
IMPL
From Benzinga
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
From Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 28, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
From Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
September 10, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 10, 2021
From InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
September 10, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 10, 2021
From Benzinga
Why Impel NeuroPharma Stock Blasted 27% Higher Thursday
September 09, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.